X0306 4 2018-12-17 false 0001271214 Intersect ENT, Inc. XENT 0001530893 Earnhardt Lisa D C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 true true false false President and CEO Common Stock 2018-12-17 4 M false 5000.00 13.05 A 399683.00 D Common Stock 2018-12-17 4 S false 20000.00 29.7252 D 379683.00 D Common Stock 26182.00 I See footnote Stock Option (right to buy) 13.05 2018-12-17 4 M false 5000.00 0.00 D 2027-01-17 Common Stock 5000.00 157000.00 D Includes 61,500 Restricted Stock Units. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 7, 2017. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.31 to $30.53, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Shares in the name of Lisa Damkroger Earnhardt C/F Jack L. Earnhardt UTMA/CA Until Age 25 for the benefit of Reporting Person's son. Reporting Person disclaims beneficial ownership of these shares. The vesting commencement date of the option is January 1, 2017. 1/8th of the shares subject to the option shall vest on July 1, 2017 and 1/48th of the shares subject to the option shall vest monthly thereafter over 42 months. /s/ David A. Lehman, Attorney-in-Fact for Earnhardt Lisa D 2018-12-19